PGK1 and glioblastoma: Radio-gene therapy utilizes nanoparticles engineered for hypoxia-triggered RNA interference, silencing critical tumor-promoting genes such as PGK1, thereby significantly sensitizing tumors like glioblastoma to concurrent chemotherapy and radiotherapy.